Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)
Clinical trial NCT04589208 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04589208
- Sponsor
- New York State Psychiatric Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2027-01-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.